Published final results of the DeCOG-SLT trial add evidence that patients who have a positive sentinel lymph-node biopsy, and have immediate complete lymph node dissection, do not achieve…
There have been many changes in the treatment landscape of stage II and stage III melanoma over the past decade. This article takes a look at the benefits…
Determining which patients are most likely to benefit from BRAF-targeted therapies was the topic of a recent review by Anna C. Pavlick, DO, MBA, of New York University…
Determining which patients are most likely to benefit from BRAF-targeted therapies was the topic of a recent review in ASCO Educational Book by Anna C. Pavlick, DO, MBA,…
A study conducted in Arizona by the Mayo Ciinic found reason to suspect that vaping is consistently associated with serious lung damage. Vaping causes a “severe chemical injury”…
Join Michael Hochman, MD, MPH, for the first episode of Updates in Slow Medicine. This installment features a brief examination of recent research regarding non-specific clinical tests and…
The common carp, a fish species that is invasive in the US Midwest, may have finally met its match. Scientists with the Minnesota Aquatic Invasive Species Research Center…
A preliminary clinical study looking at previously untreated metastatic melanoma showed promising results when treating with the combination of an IL-2 signaling agonist and nivolumab. Primary trial objectives…
Researchers at Villanova University in Philadelphia have constructed a model brain they say provides a noninvasive new way to study brain injury. A team of engineers led by…
Early data from the phase III CheckMate 067 trial, reported in September 2017, showed that patients with advanced melanoma treated with nivolumab, with or without ipilimumab, maintained their quality…
For a menopausal woman undergoing hormone therapy, breast cancer risk is significantly influenced by the specific combination of hormones she receives. That’s according to Oxford University scientists who…
